TY - JOUR T1 - Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim? JF - Breathe JO - Breathe DO - 10.1183/20734735.0056-2021 VL - 17 IS - 3 SP - 210056 AU - Adilia Warris Y1 - 2021/09/01 UR - http://breathe.ersjournals.com/content/17/3/210056.abstract N2 - Macrolides should not be used as first-line therapy for community-acquired pneumonia in children as no clinical benefit is shown and widespread use is associated with an emerging increase in macrolide resistance amongst S. pneumoniae and M. pneumoniae https://bit.ly/3yQuedF ER -